225
Participants
Start Date
July 31, 2025
Primary Completion Date
April 20, 2027
Study Completion Date
May 18, 2027
Ritlecitinib higher dose
Study intervention will be provided as oral capsules centrally by the sponsor in high-density polyethylene (HDPE) bottles.
Ritlecitinib lower dose
Study intervention will be provided as oral capsules centrally by the sponsor in HDPE bottles.
Placebo
Study intervention will be provided as oral capsules centrally by the sponsor in HDPE bottles.
RECRUITING
Pediatric Skin Research, Miami
RECRUITING
D&H Tamarac Research Center, Tamarac
RECRUITING
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RECRUITING
Complete Behavior Health (Dr. Brittany Marshall, Licensed Psychologist), Papillion
RECRUITING
Ear, Nose and Throat Consultants, LLC, Omaha
RECRUITING
Skin Specialists, PC dba Schlessinger MD, Omaha
RECRUITING
Texas Dermatology and Laser Specialists, San Antonio
RECRUITING
Austin Institute for Clinical Research, Pflugerville
RECRUITING
3A Research - West Location, El Paso
NOT_YET_RECRUITING
AMR Clinical, Layton
RECRUITING
Northwest Dermatology Institute, Portland
NOT_YET_RECRUITING
Huashan Hospital, Fudan University, Shanghai
RECRUITING
Tohoku University Hospital, Sendai
RECRUITING
Niigata University Medical & Dental Hospital, Niigata
RECRUITING
Hamamatsu University Hospital, Hamamatsu
NOT_YET_RECRUITING
Kyorin University Hospital, Mitaka
RECRUITING
Osaka Metropolitan University Hospital, Osaka
Lead Sponsor
Pfizer
INDUSTRY